5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.97▼ | 8.06▼ | 8.06▼ | 8.15▼ | 9.56▼ |
MA10 | 8.04▼ | 8.11▼ | 8.00▼ | 8.66▼ | 10.28▼ |
MA20 | 8.13▼ | 7.79▲ | 7.72▲ | 9.91▼ | 8.40▼ |
MA50 | 7.70▲ | 8.03▼ | 8.42▼ | 9.24▼ | 8.22▼ |
MA100 | 7.88▲ | 8.65▼ | 9.41▼ | 8.11▼ | 9.70▼ |
MA200 | 8.50▼ | 9.93▼ | 10.24▼ | 8.35▼ | 33.67▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.059▼ | 0.040▲ | 0.089▲ | -0.351▼ | -0.061▼ |
RSI | 46.717▼ | 48.844▼ | 46.492▼ | 38.763▼ | 46.631▼ |
STOCH | 10.275▼ | 46.154 | 64.109 | 23.345 | 53.602 |
WILL %R | -93.805▼ | -67.073 | -35.714 | -78.423▼ | -65.891 |
CCI | -120.468▼ | -23.592 | 24.012 | -87.144 | -26.592 |
Monday, March 08, 2021 07:49 AM
Applied DNA Sciences, Inc. (NASDAQ: APDN) ("Applied DNA" or the "Company"), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, will be participating in the following virtual investor ...
|
Tuesday, March 02, 2021 05:03 AM
Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and its program development partner, Evvivax, S.R.L. (“Evvivax ...
|
Friday, February 26, 2021 01:48 AM
Applied DNA Sciences (NASDAQ:APDN) reported Q1 sales of $1.62 million. Earnings fell to a loss of $2.97 million, resulting in a 26.64% decrease from last quarter. In Q4, Applied DNA Sciences ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/03/21 | 8.02 | 8.44 | 7.855 | 7.89 | 209,251 |
05/03/21 | 7.79 | 7.9499 | 6.88 | 7.93 | 296,103 |
04/03/21 | 8.73 | 8.73 | 6.85 | 7.64 | 872,547 |
03/03/21 | 9.10 | 9.10 | 8.48 | 8.78 | 520,165 |
02/03/21 | 8.78 | 9.1299 | 8.42 | 8.49 | 937,622 |
01/03/21 | 9.02 | 9.13 | 8.565 | 8.66 | 252,654 |
26/02/21 | 9.37 | 9.65 | 8.86 | 8.95 | 491,804 |
25/02/21 | 9.19 | 10.26 | 9.02 | 9.69 | 1,293,528 |
24/02/21 | 9.38 | 9.82 | 9.125 | 9.26 | 376,304 |
23/02/21 | 9.70 | 9.71 | 7.96 | 9.30 | 830,563 |
|
|
||||
|
|
||||
|
|